Midnolin is a novel regulator of parkin expression and is associated with Parkinson’s Disease
Abstract Midnolin (MIDN) was first discovered in embryonic stem cells, but its physiological and pathological roles are, to date, poorly understood. In the present study, we therefore examined the role of MIDN in detail. We found that in PC12 cells, a model of neuronal cells, MIDN localized primaril...
Guardado en:
Autores principales: | Yutaro Obara, Toru Imai, Hidenori Sato, Yuji Takeda, Takeo Kato, Kuniaki Ishii |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b0a473ce608c4da7bb4b61ac2a2f43c5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Synaptotagmin-11 is a critical mediator of parkin-linked neurotoxicity and Parkinson’s disease-like pathology
por: Changhe Wang, et al.
Publicado: (2018) -
Cognitive alterations in juvenile Parkinson´s disease caused by the C212Y mutation in the Parkin gene.
por: Sonia Moreno, et al.
Publicado: (2010) -
Hydrocortisone-induced parkin prevents dopaminergic cell death via CREB pathway in Parkinson’s disease model
por: Sangwoo Ham, et al.
Publicado: (2017) -
Lipopolysaccharide and tumor necrosis factor regulate Parkin expression via nuclear factor-kappa B.
por: Thi A Tran, et al.
Publicado: (2011) -
Deconstructing the molecular genetics behind the PINK1/Parkin axis in Parkinson’s disease using Drosophila melanogaster as a model organism
por: Suchita Ganesan, et al.
Publicado: (2021)